precision medicine

Biotech Elizabeth Cooney

Foundation Medicine wins FDA approval for liquid biopsy able to detect mutations in multiple cancers 

Biotech Matthew Herper

Turning Point releases positive data for targeted cancer drug, points to more rapid FDA filing

Health Elizabeth Cooney

Deaths from the most common lung cancer are falling fast, hinting at the impact of improved treatment

In the Lab Elizabeth Cooney

New findings about little-studied cellular compartments could help make chemo more effective

In the Lab Sharon Begley

Our body systems age at different rates, study finds, pointing to personalized care to extend healthy life

First Opinion Gwen Nichols

Precision medicine has a blind spot: children with cancer

First Opinion Amy DuRoss

To make advanced therapies, we need to industrialize personalization

In the Lab Karen Weintraub

Growing tumors in a dish, scientists try to personalize pancreatic cancer treatment

First Opinion Edward Abrahams

Personalized treatments may be threatened by drug cost-containment proposals

Health Tech Casey Ross

What if AI in health care is the next asbestos?

First Opinion Rahul Desikan

I have ALS. I wish a polygenic analysis had told me it was coming

Health Rebecca Robbins, Adam Feuerstein and Damian Garde

He went hunting for gold-standard research on artificial intelligence in medicine — and didn’t find much

First Opinion Michael J. Joyner and Nigel Paneth

Precision medicine’s rosy predictions haven’t come true. We need fewer promises and more debate

First Opinion Harris A. Gelbard

Multi-target drugs should be in the pharma pipeline along with precision drugs

Business Rebecca Robbins

With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs

First Opinion Lee D. Cooper

Genetic testing plus IVF can sidestep genetic disease and reduce the need for high-priced therapies

Biotech Jonathan Saltzman — Boston Globe

For one cancer patient, biotech’s genetic test turns out to be a ‘lifesaver’

Health Liz Szabo — Kaiser Health News

Pricey precision medicine often financially toxic for cancer patients

First Opinion Richard G. Hamermesh and Kathy E. Giusti

Precision medicine needs a business mindset in order to flourish

First Opinion Joel C. White

Administrative delays threaten the promise of the 21st Century Cures Act

First Opinion Franklin W. Maddux

Kidney disease is a killer. More precise classification can help tame it

First Opinion Robert W. Dubois

Paying for therapies that cure: innovative solutions needed

First Opinion Akbar K. Waljee, Sameer D. Saini and Brahmajee K. Nallamothu

Doctors could prescribe drugs more accurately — if they could get the data

First Opinion Chadi Nabhan

Barriers to genomic testing get in the way of precision medicine

First Opinion Eric Dishman

I handed over my genetic data to the NIH. Here’s why you should, too